Rejuvenation Technologies
Rejuvenation Technologies develops nucleoside-modified TERT mRNA used to extend telomeres, based on the technology that telomere shortening affects cell function. The company has developed in-vivo based therapeutics and cell therapies for aging and treating fatal diseases. Founded in 2012 in Mountain View, United States, the company has raised $15.2M in seed funding from investors including Khosla Ventures, Y…
Funding snapshot
About
Rejuvenation Technologies develops nucleoside-modified TERT mRNA used to extend telomeres, based on the technology that telomere shortening affects cell function. The company has developed in-vivo based therapeutics and cell therapies for aging and treating fatal diseases. Founded in 2012 in Mountain View, United States, the company has raised $15.2M in seed funding from investors including Khosla Ventures, Y Combinator, and LifeSpan Vision Ventures. Rejuvenation Technologies is developing nucleoside-modified TERT mRNA. The nucleoside-modified TERT mRNA is used to extend the telomeres. It is based on the technology that telomere shortening affects cell function. Founded in 2012, headquartered in Mountain View, United States.
Business model
Pulmonology > Drugs > Pulmonary Fibrosis > Telomere Based,
Gastroenterology > Drugs > Liver Diseases,
Genomics > Applied Genomics > Clinical Genomics > Therapeutics,
Y Combinator Batches > 2019 > Summer
Team background
College Wise > Stanford University
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.
Raising like Rejuvenation Technologies?
Analyze your pitch deck before your next raise.
Analyze My Deck →